We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Sandbox GGC7
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | == | + | ==Name of your molecule== |
| - | <StructureSection load=' | + | <StructureSection load='5CSR' size='340' side='right' caption='Triose phosphate isomerase' scene=''> |
| - | ''' | + | This is a default text for your page '''Sandbox GGC7'''. Click above on '''edit this page''' to modify. Be careful with the < and > signs. |
| + | You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue. | ||
== Function == | == Function == | ||
| - | |||
| - | It is mostly associated with disease and abnormal function in the brain. It is unclear if there is a normal function of this protein, but there is research suggesting it plays a role in neural development (1).It is associated with neurodegenerative diseases such as Alzheimer's, and possibly dementia (2). Trypsin IV is found in glial cells and astrocytes (2). It breaks down proteins in the brain and forms aggregates called amyloids (2). These sticky structures harden and form plaque (2). | ||
| - | |||
| - | Progressive accumulation of plaque in the brain is what causes Alzheimer's. There are inhibitors of this protein present in the brain, but it is able to defend against them because it is too big to fit into the active site of the inhibitor (2). This protein is highly conserved, but in humans, there is a change in one of its residues, which is responsible for the immunity to its inhibitor. Gly193 has become Arginine in humans, and it can cause disease. | ||
== Disease == | == Disease == | ||
| - | The disease it is most often associated with is Alzheimer's. The change from Gly193 to Arg193 disrupts normal brain activity. Arginine is much larger than Glycine, which causes steric hinderance in the active site of its inhibitor, APP (Amyloid Precursor Protein) trypsin inhibitor. Arginine is also positively charged which also interferes with the inhibitor. When APP Trypsin inhibitor cannot do its job, brain trypsin will start degrading other proteins in the brain and form amyloid (plaque). The plaque blocks nerve impulses. It starts in the hyppocampus, but will spread to other parts of the brain. | ||
== Relevance == | == Relevance == | ||
| - | This protein shows that trypsins are not limited to the pancreas, but its main relevance today is the fact that it is a primary cause of Alzheimer's. Research involving human trypsin IV is vital to the search for the disease which affects millions. | ||
== Structural highlights == | == Structural highlights == | ||
| + | |||
| + | This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes. | ||
</StructureSection> | </StructureSection> | ||
| - | This portion of the protein contains <scene name='75/752270/Ggc7/9'>Arg193</scene> which provides resistance to the inhibitor due to its large size and positive charge (2). | ||
| - | Another significant feature of this protein is <scene name='75/752270/Ggc7/7'>Tyr150</scene> , which has an aromatic ring that interferes with the mobility of Arg193 and helps stabilize it (2). This protein is similar to human trypsin I, but has a few notable differences, such as a <scene name='75/752270/Ggc7/8'>Threonine in position 21</scene> instead of Asparagine. | ||
== References == | == References == | ||
| - | |||
| - | 1.Wang, Y., Luo, W., & Reiser, G. (2008). Trypsin and trypsin-like proteases in the brain: proteolysis and cellular functions. Cellular And Molecular Life Sciences: CMLS, 65(2), 237-252. | ||
| - | |||
| - | 2. Katona, G., Berglund, G., Hajdu, J., Gráf, L., & Szilágyi, L. (2002). Crystal structure reveals basis for the inhibitor resistance of human brain trypsin 1 1 Edited by R. Huber. Journal of Molecular Biology, 315(5), 1209-1218. | ||
| - | |||
<references/> | <references/> | ||
Revision as of 22:25, 17 September 2019
Name of your molecule
| |||||||||||
References
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
